{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:04:02Z","timestamp":1794330242796,"version":"4.9.0"},"reference-count":32,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T00:00:00Z","timestamp":1712793600000},"content-version":"unspecified","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018562","name":"Steno Diabetes Center Copenhagen","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100018562","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF18OC0052457"],"award-info":[{"award-number":["NNF18OC0052457"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["848011"],"award-info":[{"award-number":["848011"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Diab Res Care"],"accepted":{"date-parts":[[2024,3,16]]},"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Diabetic retinopathy (DR), diabetic kidney disease (DKD) and distal symmetric polyneuropathy (DSPN) share common pathophysiology and pose an additive risk of early mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Research design and methods<\/jats:title>\n                    <jats:p>In adults with type 1 diabetes, 49 metabolites previously associated with either DR or DKD were assessed in relation to presence of DSPN. Metabolites overlapping in significance with presence of all three complications were assessed in relation to microvascular burden severity (additive number of complications\u2014ie, presence of DKD\u00b1DR\u00b1DSPN) using linear regression models. Subsequently, the same metabolites were assessed with progression to endpoints: soft microvascular events (progression in albuminuria grade, \u226530%\u2009estimated glomerular filtration rate (eGFR) decline, or any progression in DR grade), hard microvascular events (progression to proliferative DR, chronic kidney failure, or \u226540%\u2009eGFR decline), and hard microvascular or macrovascular events (hard microvascular events, cardiovascular events (myocardial infarction, stroke, or arterial interventions), or cardiovascular mortality), using Cox models. All models were adjusted for sex, baseline age, diabetes duration, systolic blood pressure, HbA1c, body mass index, total cholesterol, smoking, and statin treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The full cohort investigated consisted of 487 participants. Mean (SD) follow-up was 4.8 (2.9, 5.7) years. Baseline biothesiometry was available in 202 participants, comprising the cross-sectional cohort. Eight metabolites were significantly associated with presence of DR, DKD, and DSPN, and six with additive microvascular burden severity. In the full cohort longitudinal analysis, higher levels of 3,4-dihydroxybutanoic acid (DHBA), 2,4-DHBA, ribonic acid, glycine, and ribitol were associated with development of events in both crude and adjusted models. Adding 3,4-DHBA, ribonic acid, and glycine to a traditional risk factor model improved the discrimination of hard microvascular events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>While prospective studies directly assessing the predictive ability of these markers are needed, our results strengthen the role of clinical metabolomics in relation to risk assessment of diabetic complications in chronic type 1 diabetes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjdrc-2023-003973","type":"journal-article","created":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T13:10:17Z","timestamp":1712841017000},"page":"e003973","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Circulating metabolomic markers in association with overall burden of microvascular complications in type 1 diabetes"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4270-6701","authenticated-orcid":false,"given":"Viktor","family":"Rotbain Curovic","sequence":"first","affiliation":[{"name":"Steno Diabetes Center Copenhagen, Herlev, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brede A","family":"S\u00f8rland","sequence":"additional","affiliation":[{"name":"Steno Diabetes Center Copenhagen, Herlev, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tine W","family":"Hansen","sequence":"additional","affiliation":[{"name":"Steno Diabetes Center Copenhagen, Herlev, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddhi Y","family":"Jain","sequence":"additional","affiliation":[{"name":"Steno Diabetes Center Copenhagen, Herlev, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Sulek","sequence":"additional","affiliation":[{"name":"Steno Diabetes Center Copenhagen, Herlev, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismo Matias","family":"Mattila","sequence":"additional","affiliation":[{"name":"Steno Diabetes Center Copenhagen, Herlev, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8486-1515","authenticated-orcid":false,"given":"Marie","family":"Frimodt-Moller","sequence":"additional","affiliation":[{"name":"Steno Diabetes Center Copenhagen, Herlev, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kajetan","family":"Trost","sequence":"additional","affiliation":[{"name":"Steno Diabetes Center Copenhagen, Herlev, Denmark"},{"name":"Department of Clinical Medicine, University of Copenhagen, K\u00f8benhavn, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Legido-Quigley","sequence":"additional","affiliation":[{"name":"Steno Diabetes Center Copenhagen, Herlev, Denmark"},{"name":"King's College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Theilade","sequence":"additional","affiliation":[{"name":"Steno Diabetes Center Copenhagen, Herlev, Denmark"},{"name":"Department of Clinical Medicine, University of Copenhagen, K\u00f8benhavn, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nete","family":"Tofte","sequence":"additional","affiliation":[{"name":"Steno Diabetes Center Copenhagen, Herlev, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Signe Abitz","family":"Winther","sequence":"additional","affiliation":[{"name":"Steno Diabetes Center Copenhagen, Herlev, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian Stevns","family":"Hansen","sequence":"additional","affiliation":[{"name":"Steno Diabetes Center Copenhagen, Herlev, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1531-4294","authenticated-orcid":false,"given":"Peter","family":"Rossing","sequence":"additional","affiliation":[{"name":"Steno Diabetes Center Copenhagen, Herlev, Denmark"},{"name":"Department of Clinical Medicine, University of Copenhagen, K\u00f8benhavn, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7464-3354","authenticated-orcid":false,"given":"Tarunveer S","family":"Ahluwalia","sequence":"additional","affiliation":[{"name":"Steno Diabetes Center Copenhagen, Herlev, Denmark"},{"name":"University of Copenhagen Bioinformatics Centre, K\u00f8benhavn, Denmark"},{"name":"Department of Science and Environment, Roskilde University, Roskilde, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,4,11]]},"reference":[{"key":"2025073111505864000_12.2.e003973.1","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/S0140-6736(18)31320-5","article-title":"Type 1 diabetes","volume":"391","author":"DiMeglio","year":"2018","journal-title":"The Lancet"},{"key":"2025073111505864000_12.2.e003973.2","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-019-0961-7","article-title":"Microvascular complications burden (nephropathy, retinopathy and peripheral polyneuropathy) affects risk of major vascular events and all-cause mortality in type 1 diabetes: a 10-year follow-up study","volume":"18","author":"Garofolo","year":"2019","journal-title":"Cardiovasc Diabetol"},{"key":"2025073111505864000_12.2.e003973.3","unstructured":"International Diabetes Federation . IDF Diabetes Atlas.10th edn. Brussels, Belgium, 2021."},{"key":"2025073111505864000_12.2.e003973.4","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.831793","article-title":"Cardiovascular autonomic neuropathy in type 1 diabetes is associated with disturbances in TCA, lipid, and glucose metabolism. front Endocrinol (Lausanne)","volume":"13","author":"Hansen","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025073111505864000_12.2.e003973.5","doi-asserted-by":"crossref","first-page":"818","DOI":"10.3389\/fendo.2019.00818","article-title":"Metabolomic assessment reveals alteration in polyols and branched chain amino acids associated with present and future renal impairment in a discovery cohort of 637 persons with type 1 diabetes. front Endocrinol (Lausanne)","volume":"10","author":"Tofte","year":"2019","journal-title":"Front Endocrinol"},{"key":"2025073111505864000_12.2.e003973.6","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-52916-w","article-title":"Lipidomic analysis reveals sphingomyelin and phosphatidylcholine species associated with renal impairment and all-cause mortality in type 1 diabetes","volume":"9","author":"Tofte","year":"2019","journal-title":"Sci Rep"},{"key":"2025073111505864000_12.2.e003973.7","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-0737"},{"key":"2025073111505864000_12.2.e003973.8","doi-asserted-by":"publisher","DOI":"10.2337\/db20-2217-PUB"},{"key":"2025073111505864000_12.2.e003973.9","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-022-01652-z","article-title":"The novel inflammatory biomarker glyca and triglyceride-rich lipoproteins are associated with the presence of subclinical myocardial dysfunction in subjects with type 1 diabetes mellitus","volume":"21","author":"Puig-Jov\u00e9","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"2025073111505864000_12.2.e003973.10","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-022-01568-8","article-title":"Circulating metabolites and molecular lipid species are associated with future cardiovascular morbidity and mortality in type 1 diabetes","volume":"21","author":"Ferreira-Divino","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"2025073111505864000_12.2.e003973.11","doi-asserted-by":"crossref","unstructured":"Andersen JA , Suvitaival T , Tro\u0161t K , et al . Metabolomic risk predictors of diabetic foot complications: a longitudinal observational study in type 1 diabetes. Endocrinology (including Diabetes Mellitus and Metabolic Disease) [Preprint] 2023. doi:10.1101\/2022.05.16.22275166","DOI":"10.1101\/2022.05.16.22275166"},{"key":"2025073111505864000_12.2.e003973.12","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-0850"},{"key":"2025073111505864000_12.2.e003973.13","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"key":"2025073111505864000_12.2.e003973.14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1464-5491.1991.tb01563.x","article-title":"Vibration perception threshold: influence of age, height, sex, and smoking, and calculation of accurate Centile values","volume":"8","author":"Wiles","year":"1991","journal-title":"Diabet Med"},{"key":"2025073111505864000_12.2.e003973.15","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.2337\/dc23-0312","article-title":"Declining incidence rates of distal symmetric polyneuropathy in people with type 1 and type 2 diabetes in Denmark, with indications of distinct patterns in type 1 diabetes","volume":"46","author":"Mizrak","year":"2023","journal-title":"Diabetes Care"},{"key":"2025073111505864000_12.2.e003973.16","unstructured":"Kidney disease: improving global outcomes (KDIGO) CKD work group . KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Inter 2013;1\u2013150."},{"key":"2025073111505864000_12.2.e003973.17","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(03)00475-5"},{"key":"2025073111505864000_12.2.e003973.18","doi-asserted-by":"publisher","DOI":"10.1021\/ac103308x"},{"key":"2025073111505864000_12.2.e003973.19","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1015557","article-title":"Multiomics signatures of type 1 diabetes with and without albuminuria","volume":"13","author":"Clos-Garcia","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025073111505864000_12.2.e003973.20","doi-asserted-by":"publisher","DOI":"10.1530\/ec-19-0012"},{"key":"2025073111505864000_12.2.e003973.21","doi-asserted-by":"crossref","DOI":"10.3390\/nu11061356","article-title":"Glycine metabolism and its alterations in obesity and metabolic diseases","volume":"11","author":"Alves","year":"2019","journal-title":"Nutrients"},{"key":"2025073111505864000_12.2.e003973.22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0224274","article-title":"Metabolomics profiles associated with Hba1C levels in patients with type 2 diabetes","volume":"14","author":"Yun","year":"2019","journal-title":"PLoS One"},{"key":"2025073111505864000_12.2.e003973.23","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-68130-y","article-title":"Liver nucleotide biosynthesis is linked to protection from vascular complications in individuals with long-term type 1 diabetes","volume":"10","author":"Jain","year":"2020","journal-title":"Sci Rep"},{"key":"2025073111505864000_12.2.e003973.24","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002621","article-title":"Plasma glycine and risk of acute myocardial infarction in patients with suspected stable angina Pectoris","volume":"5","author":"Ding","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"2025073111505864000_12.2.e003973.25","doi-asserted-by":"publisher","DOI":"10.2337\/diab.34.1.67"},{"key":"2025073111505864000_12.2.e003973.26","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0168-8227(88)80091-3","article-title":"Rapid changes in urinary Serine and branched-chain amino acid excretion among diabetic patients during insulin treatment","volume":"5","author":"Sasaki","year":"1988","journal-title":"Diabetes Res Clin Pract"},{"key":"2025073111505864000_12.2.e003973.27","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-011-0291-6"},{"key":"2025073111505864000_12.2.e003973.28","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-022-03629-8","article-title":"Sglt2 inhibitors improve kidney function and morphology by regulating renal metabolic Reprogramming in mice with diabetic kidney disease","volume":"20","author":"Lu","year":"2022","journal-title":"J Transl Med"},{"key":"2025073111505864000_12.2.e003973.29","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.62.12.4"},{"key":"2025073111505864000_12.2.e003973.30","doi-asserted-by":"crossref","unstructured":"American diabetes Association professional practice committee . Chronic kidney disease and risk management: standards of care in Diabetes\u20142024. Diabetes Care 2023;S219\u201330.","DOI":"10.2337\/dc24-S011"},{"key":"2025073111505864000_12.2.e003973.31","doi-asserted-by":"crossref","first-page":"S231","DOI":"10.2337\/dc24-S012","article-title":"Retinopathy, neuropathy, and foot care: standards of care in Diabetes\u20142024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"key":"2025073111505864000_12.2.e003973.32","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","article-title":"Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables","volume":"6","author":"Ahlqvist","year":"2018","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["BMJ Open Diabetes Research &amp; Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjdrc-2023-003973","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T18:51:08Z","timestamp":1753987868000},"score":1,"resource":{"primary":{"URL":"https:\/\/drc.bmj.com\/lookup\/doi\/10.1136\/bmjdrc-2023-003973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":32,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,4,11]]},"published-print":{"date-parts":[[2024,4]]}},"alternative-id":["10.1136\/bmjdrc-2023-003973"],"URL":"https:\/\/doi.org\/10.1136\/bmjdrc-2023-003973","relation":{},"ISSN":["2052-4897"],"issn-type":[{"value":"2052-4897","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4]]}}}